Analyst upgrades typically lead to a positive short-term reaction in the stock market as they reflect a positive change in the analyst's view on the company's future performance. This upgrade suggests Wolfe Research has a more favorable outlook on Ionis Pharmaceuticals' prospects, potentially leading to increased investor interest and a rise in stock price.